Midgard Science

Labs / Assays & in vitro testing

Probiocdmo

Nanjing, China · probiocdmo.com

GMP

ProBio is a global CRDMO that provides discovery, development, and manufacturing services for biologics, cell and gene therapy, mRNA, plasmid DNA, viral vectors, and in vivo CAR-T programs. It serves biotech and pharmaceutical companies from sites in the United States, China, the Netherlands, and South Korea, with U.S. operations in New Jersey.

They take quote requests by email.

What they offer

  • Therapeutic antibody discovery

    Provides target discovery, lead generation, lead optimization, in vitro bioassays, in vivo validation, and developability assessment for antibody programs.

  • Monoclonal and bispecific antibody development

    Supports discovery, cell line development, process optimization, characterization, validation, and GMP manufacturing for monoclonal and bispecific antibodies.

  • ADC discovery and development

    Delivers antibody discovery, payload-linker selection, conjugation optimization, bioassays, pharmacology, and IND-enabling CMC for antibody-drug conjugates.

  • In vivo CAR-T development

    Supports discovery through IND-enabling CMC for in vivo CAR-T using plasmid, antibody, mRNA-LNP, and targeted lentiviral vector platforms.

  • mRNA vaccine development and manufacturing

    Provides plasmid DNA production, IVT-mRNA manufacturing, LNP encapsulation, analytical testing, GMP production, and fill-finish services.

  • Plasmid DNA services

    Offers plasmid-related services for CGT and vaccine programs, including linearized DNA manufacturing and plasmid CMC support.

  • Viral vector services

    Provides lentiviral vector development, packaging, concentration, purification, and GMP manufacturing support.

  • Cell and gene therapy CMC services

    Supports cell banking, process development, characterization, validation, analytical development, and stability studies for CGT programs.

What they work on

Modalities
Antibody, Bispecific, ADC, mRNA, Viral vector, Cell therapy, Vaccine, Plasmid DNA, LNP / formulation
Species and models
HEK293T cells, CHO-K1, hybridoma, single B cell screening, phage display
Assays and studies
in vitro bioassays, cell-based bioassays, developability assessment, bioanalytical development, analytical testing, pharmacology studies, efficacy and safety evaluation, internalization bioassay, cytotoxicity assay, bystander effect study, pharmacodynamics, pharmacokinetics, and 1 more
Instruments and platforms
SEC-HPLC, HIC-HPLC
Scale and capacity
2000L drug substance manufacturing, 50-2000 L GMP manufacturing, GMP biologics manufacturing facility in New Jersey
Therapeutic areas
oncology, autoimmune diseases, infectious disease, genetic medicine
Turnaround
PCC in as little as 6 months · DNA to tox batch in 4 months · CLD: DNA to 6 top clones in 10 weeks · 3–5 months · 5–6 months · 7–9 months
What to send
Target and mechanism of action information · DNA for cell line development and CMC workflows
Type
CRDMO
Sites
Hopewell, New Jersey, United States · Nanjing, China · Hong Kong, China · Shanghai, China · the Netherlands, Netherlands · South Korea, South Korea
Quality
FDA (Phase-appropriate compliance; GMP capacity meeting regulatory requirements) · EMA (Phase-appropriate compliance; GMP capacity meeting regulatory requirements) · NMPA (Phase-appropriate compliance; GMP capacity meeting regulatory requirements)
Serves
United States, Europe, Asia Pacific, EMEA

Similar labs. Sparx BIO, Evotec, Aurigene Pharmaceutical Services, 3C Therapeutics

Found in a contract services directory. Listing built from probiocdmo.com. Work here? Claim this listing.